SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Verismo Therapeutics to Present First-in-Human KIR-CAR Clinical Data at ASH

Interim data for the CD19-targeted KIR-CAR T therapy showed no CRS or ICANS, according to the supplied body.

Related stories